These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23805768)

  • 1. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pro medicine or pro pharma?].
    Schroll JB
    Ugeskr Laeger; 2013 Nov; 175(48):2968-9. PubMed ID: 26504924
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 6. Dosing information for paediatric patients: are they really "therapeutic orphans"?
    Caswell AJ
    Med J Aust; 2003 Nov; 179(10):560. PubMed ID: 14609429
    [No Abstract]   [Full Text] [Related]  

  • 7. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines for drug administration for dialysis patients].
    Nakamoto M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():80-6. PubMed ID: 15250273
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic comparison of four sources of drug information regarding adjustment of dose for renal function.
    Vidal L; Shavit M; Fraser A; Paul M; Leibovici L
    BMJ; 2005 Jul; 331(7511):263. PubMed ID: 15905228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
    Khanal A; Castelino RL; Peterson GM; Jose MD
    Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
    Lalonde RL; Wagner JA
    Clin Pharmacol Ther; 2009 Nov; 86(5):557-61. PubMed ID: 19776736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIMS is not a stand-alone resource.
    Donohoo EA
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484718
    [No Abstract]   [Full Text] [Related]  

  • 13. The National Prescribing Service should lead.
    Stockigt JR
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484717
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose individualization in PharmDIS-e+.
    Proost JH; Punt NC
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):451-8. PubMed ID: 14703950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label.
    Menon-Andersen D; Yu B; Madabushi R; Bhattaram V; Hao W; Uppoor RS; Mehta M; Lesko L; Temple R; Stockbridge N; Laughren T; Gobburu JV
    Clin Pharmacol Ther; 2011 Sep; 90(3):471-4. PubMed ID: 21796114
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose adjustment in renal impairment: response from the British National Formulary.
    Mehta DK
    BMJ; 2005 Jul; 331(7511):292. PubMed ID: 16052025
    [No Abstract]   [Full Text] [Related]  

  • 17. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicines and breastfeeding: information is available on safe use.
    Amir LH
    Med J Aust; 2007 May; 186(9):485. PubMed ID: 17484719
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine.
    Sweileh WM; Janem SA; Sawalha AF; Abu-Taha AS; Zyoud SH; Sabri IA; Al-Jabi SW; Jaradat NA; Zaid AA
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):908-12. PubMed ID: 17464934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Presence of excipients in pharmaceutical products in 3 sources of therapeutic information].
    Altimiras J; Nieto-Hernández T; Buitrago F
    Aten Primaria; 1996 Sep; 18(4):190-3. PubMed ID: 8963000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.